文献速递急性肾损伤

成人COVID-19患者急性肾损伤的发病率、危险因素与预后

The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-09-22

这项回顾性队列研究纳入1392例住院COVID-19成人患者,按2012 KDIGO标准定义并分期AKI。结果显示7%发生AKI,重症、基线肌酐升高、淋巴细胞减少及D-二聚体升高为危险因素,且AKI与住院死亡独立相关。

要点

  • COVID-19住院成人AKI发生率为7%,其中40%在入院1周内出现。
  • 重症、高基线肌酐、淋巴细胞减少及D-二聚体升高与AKI风险升高相关。
  • AKI与住院死亡独立相关,调整混杂后OR为5.12。

核心结论

  • COVID-19成人患者中AKI并不常见,但合并AKI时住院死亡率高。

研究设计与样本

  • 回顾性队列研究,纳入某三级教学医院收治的1392例COVID-19成人患者,从电子住院与实验室数据库提取临床及实验室数据。
  • AKI按2012 KDIGO标准定义并分期。

主要发现

  • 7%(99/1392)的患者住院期间发生AKI,其中40%(40/99)在入院1周内发生。
  • 与AKI风险升高相关的因素包括重症(OR 2.25,95%CI 1.37–3.67)、较高基线血清肌酐(OR 2.19,95%CI 1.17–4.11)、淋巴细胞减少(OR 1.99,95%CI 1.12–3.53)及D-二聚体升高(OR 2.68,95%CI 1.07–6.70)。
  • AKI 1期、2期、3期患者住院死亡率分别为62%、77%、80%。
  • 调整混杂因素后,AKI仍与住院死亡相关(OR 5.12,95%CI 2.70–9.72)。

关键数值与推荐

  • AKI定义与分期采用2012 KDIGO标准。
  • AKI发生率7%(99/1392),40%(40/99)发生于入院1周内。
  • AKI 1、2、3期住院死亡率分别为62%、77%、80%。
  • AKI与住院死亡独立相关,OR 5.12(95%CI 2.70–9.72)。

临床怎么用

  • 对COVID-19住院患者应关注AKI风险,尤其重症、基线肌酐升高、淋巴细胞减少或D-二聚体升高者。
  • 发生AKI的COVID-19患者住院死亡风险高,需加强监测与支持治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Since December 2019, coronavirus disease 2019 (COVID-19) outbreak occurred and has rapidly spread worldwide. However, little information is available about the AKI in COVID-19. We aimed to evaluate the incidence, risk factors, and prognosis of AKI in adult patients with COVID-19. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a retrospective cohort study of 1392 patients with COVID-19 admitted to a tertiary teaching hospital. Clinical characteristics and laboratory data were extracted from electronic hospitalization and laboratory databases. AKI was defined and staged according to the 2012 Kidney Disease: Improving Global Outcomes criteria. Risk factors for AKI and the association of AKI with in-hospital mortality were assessed. RESULTS: A total of 7% (99 of 1392) of patients developed AKI during hospitalization, 40% (40 of 99) of which occurred within 1 week of admission. Factors associated with a higher risk of AKI include severe disease (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.37 to 3.67), higher baseline serum creatinine (OR, 2.19; 95% CI, 1.17 to 4.11), lymphopenia (OR, 1.99; 95% CI, 1.12 to 3.53), and elevated D-dimer level (OR, 2.68; 95% CI, 1.07 to 6.70). The in-hospital mortality in patients with AKI stage 1, stage 2, and stage 3 was 62%, 77%, and 80%, respectively. AKI was associated with in-hospital mortality even after adjustment for confounders (OR, 5.12; 95% CI, 2.70 to 9.72). CONCLUSIONS: AKI is uncommon but carries high in-hospital mortality in patients with COVID-19.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Cheng Y, Luo R, Wang X, et al. The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019. Clin J Am Soc Nephrol. 2020. PMID: 32963018. doi:10.2215/CJN.04650420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。